UAB will be a fundamental player in the Alabama jurisdiction of the program, which has just five awardees, with primary goals of improving scientific research and building workforce capacity.
Published in Research
This active drug-delivery system addresses the limitations seen for the anti-cancer drug BA-TPQ — poor solubility and low bioavailability.
Published in Research
The NSF will support a UAB/BBA collaboration through a $600,000 award — the first Partnership for Innovation grant ever given in Alabama.
Published in Research
Back to Top